The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats.

Saved in:
Bibliographic Details
Title: The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats.
Authors: Duttaroy A; Novartis Institutes for Biomedical Research, Inc., 100 Technology Square, Cambridge, MA 02139, USA., Voelker F, Merriam K, Zhang X, Ren X, Subramanian K, Hughes TE, Burkey BF
Source: European journal of pharmacology [Eur J Pharmacol] 2011 Jan 15; Vol. 650 (2-3), pp. 703-7. Date of Electronic Publication: 2010 Nov 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0712
DOI:10.1016/j.ejphar.2010.10.062